Trials / Not Yet Recruiting
Not Yet RecruitingNCT06482307
Molecular Imaging of DNA Damage Response by [18F]-Olaparib PET
- Status
- Not Yet Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- University Medical Center Groningen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a single-centre, non-randomized, two-stage design, proof-of-concept study evaluating the radiolabelled PARP inhibitor \[18F\]-olaparib als potential tracer for imaging of tumour PARP expression by PET.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | [18F]-olaparib PET scan | The IMP investigated is \[18F\]Olaparib, a radiolabelled PARP inhibitor suitable for PET imaging. |
Timeline
- Start date
- 2025-05-01
- Primary completion
- 2026-02-01
- Completion
- 2026-02-01
- First posted
- 2024-07-01
- Last updated
- 2025-04-18
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT06482307. Inclusion in this directory is not an endorsement.